Study to Assess the Relationship Between Daily Dosing of NRPT and Changes in Liver Fat in Healthy Volunteers
Public ClinicalTrials.gov record NCT03513523. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled Study to Assess the Relationship Between Daily Dosing of NRPT and Changes in Liver Fat in Healthy Volunteers
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine if there is a relationship between daily consumption of NRPT, over a six-month (26-week) period, and changes in liver fat accumulation, compared to placebo and change from Baseline in healthy volunteers. In addition, an exploratory assessment of markers of inflammation and liver fat metabolism will be examined.
Study identification
- NCT ID
- NCT03513523
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 111 participants
Conditions and interventions
Conditions
Interventions
- Group 1 NRPT Dietary Supplement
- Group 2 NRPT Dietary Supplement
- Group 3 Placebo Other
Dietary Supplement · Other
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 18, 2018 (Actual)
- Primary completion
- May 10, 2020 (Actual)
- Completion
- Aug 17, 2020 (Actual)
- Last update posted
- Oct 26, 2020
2018 – 2020
United States locations
- U.S. sites
- 9
- U.S. states
- 3
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Indago Research and Health Center | Hialeah | Florida | 33012 | — |
| Altus Research, Inc. | Lake Worth | Florida | 33461 | — |
| Lone Star Research Center | Miami | Florida | 33145 | — |
| Med-Care Research Corp | Miami | Florida | 33165 | — |
| Legacy Clinical Solutions: Sensible Healthcare, LLC | Ocoee | Florida | 34761 | — |
| IMIC, Inc | Palmetto Bay | Florida | 33157 | — |
| Lenus Research & Medical Group | Sweetwater | Florida | 33172 | — |
| Barrett Clinic, P.C. | La Vista | Nebraska | 68128 | — |
| Trial Management Associates, LLC | Wilmington | North Carolina | 28403 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03513523, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 26, 2020 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03513523 live on ClinicalTrials.gov.